Risk Placement Services, the E&S wholesale broker and managing general agency, is pleased to announce its President Joel Cavaness has been named the 2022 Spirit of Life® Honoree by City of Hope, one of the largest cancer research and treatment organizations in the United States.
The Spirit of Life® Award is City of Hope's most prestigious honor, presented to an esteemed community of industry leaders around the world who have made a significant commitment to support those in need.
This year, the City of Hope's National Insurance Industry Council (NIIC) honors Cavaness and will commemorate this recognition during the Spirit of Life® Gala September 11 in San Diego.
"Spirit of Life® honorees are selected for their notable contributions to the community in which they live and the profession in which they work," said City of Hope Senior Director Ken Birkett. "Joel leads by example in his passion for and commitment to community involvement, fostering a culture of charitable giving within RPS. He truly embodies our mission at City of Hope to make a difference in the lives of people with cancer, diabetes and other life-threatening illnesses."
Ahead of the Spirit of Life® Gala, Cavaness set a goal to raise $1 million from fellow insurance leaders to support City of Hope.
"I'm honored and humbled to receive this recognition," Cavaness said. "I am in awe of the medical professionals, researchers and administrators who have dedicated their careers to serve the City of Hope. Through great partnerships, such as the NIIC, we can further their important work and help save more lives."
About Risk Placement Services
Risk Placement Services (RPS) is one of the nation's largest specialty insurance products distributors, offering valuable solutions in wholesale brokerage, binding authority, programs and standard lines, plus specialized auto through its Pronto Insurance brand. Headquartered in Rolling Meadows, Illinois, RPS has more than 80 offices nationwide. For more information, visit RPSins.com. Follow RPS on Facebook, Twitter, LinkedIn, Instagram and YouTube.
About City of Hope
City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients, spanning cancer care, research and development, academics and training, and innovation initiatives. Research and technology developed at City of Hope has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. A leader in bone marrow transplantation and immunotherapy, such as CAR T cell therapy, City of Hope's personalized treatment protocols help advance cancer care throughout the world.
With a goal of expanding access to the latest discoveries and leading-edge care to more patients, families and communities, City of Hope's growing national system includes its main Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California and Cancer Treatment Centers of America. City of Hope's affiliated family of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.